Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
   
Monday 09 November 2009
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 270, 522 - 524 (08 December 1977); doi:10.1038/270522a0

Absence of suppressor cells from rats bearing passively enhanced kidney allografts

J. R. BATCHELOR, L. BRENT & P. J. KILSHAW*‡

McIndoe Research Unit, Queen Victoria Hospital, East Grinstead, Sussex, UK
Department of Immunology, St Mary's Hospital Medical School, London W2, UK
*Present address: Nutrition Department, National Institute for Research in Dairying, Shinfield, Reading, Berkshire, UK.

LYMPHOCYTES which inhibit the immunological responses of other lymphocytes are known as suppressor cells, and such cells have been shown to mediate both specific and nonspecific unresponsiveness in many experimental situations1−3. In the context of allotransplantation, Kilshaw et al. 4,5 have found that the highly strain-specific unresponsiveness to skin allografts induced in adult mice by pretreatment with donor strain tissue extract and Bordetella pertussis vaccine, followed by a short post-operative course of antilymphocyte serum (ALS), is at least in part mediated by thymus-dependent lymphocytes. Thus, transfer of 25−100 times 106 spleen cells (optimally the lower dose5) from mice in the stable phase of unresponsiveness into ALS-treated syngeneic recipients established a long-lasting unresponsiveness to donor strain skin grafts in up to 50% of recipients. Because the nature of the mechanisms of immunological enhancement of kidney allografts in rats remain unclear6−8 we have carried out cell transfer experiments similar to those of Kilshaw et al. in order to discover whether suppressor cells also play a part in mediating the stable phase of the enhanced state. Fabre and Morris9 have previously failed to transfer unresponsiveness with spleen cells from rats with enhanced kidneys, but it is possible that transfer of cells to normal, syngeneic rats—as in their experiments—is an insufficiently sensitive method for detecting suppressor cells. Our results show that it is unlikely that suppressor cells or auto-anti-idiotype antibodies are responsible for the steady state of enhancement. A more likely explanation involves the induction of unresponsiveness by the continuous exposure of the recipient to histocompatibility antigens in the absence of Ia-like antigens—the latter determinants being obligatory requirements for the activation of T cells 'helping' both potentially reactive B cells and T cells capable of differentiating into killer cells.

------------------

References
1. Gershon, R. K. Transpl. Rev. 26, 170–185 (1975).
2. Tada, T., Taniguchi, M. & Takemori, T. Transpl. Rev. 26, 106–129 (1975).
3. R. W. Dresser (ed.) Immunological Tolerance, Br. med. Bull. 32, 99–191 (1976).
4. Kilshaw, P. J., Brent, L. & Pinto, M. Nature 255, 489–491 (1975).
5. Kilshaw, P. J. & Brent, L. Transpl. Proc. 9, 717–719 (1977).
6. French, M. E. & Batchelor, J. R. Transpl. Rev. 13, 115–141 (1972).
7. Batchelor, J. R. & Welsh, K. I. Br. med. Bull. 32, 113–117 (1976).
8. Carpenter, C. B. d'Apice, A. J. B. & Abbas, A. K. Adv. Immun. 22, 1–65 (1976).
9. Fabre, J. W. & Morris, P. J. Transplantation 14, 634–640 (1972).
10. Binz, H., Lindenmann, J. & Wigzell, H. J. exp. Med. 140, 731–741 (1974).
11. Binz, H. & Wigzell, H. J. exp. Med. 142, 197–211 (1975).
12. Binz, H. & Wigzell, H. Nature 262, 294–295 (1976).
13. Binz, H. & Wigzell, H. Nature 264, 778–780 (1976).
14. McKearn, T. J., Stuart, F. P. & Fitch, F. W. J. Immun. 113, 1876–1882 (1974).
15. Stuart, F. P., Scollard, D. M., McKearn, T. J. & Fitch, F. W. Transplantation 22, 455–466 (1976).
16. Anderson, L. C., Binz, H. & Wigzell, H. Nature 264, 778–780 (1976).
17. Cantor, H. & Boyse, E. A. J. exp. Med. 141, 1376–1389; 1390–1399 (1975).
18. Klein, J., Livnat, S., Hauptfeld, V., Jerábek, L. & Weissman, I. Eur. J. Immun. 4, 41–44 (1974).
19. Rolstad, B., Williams, A. F. & Ford, W. L. Transplantation 17, 416–423 (1974).
20. Eijsvoogel, V. P. et al. Transpl. Proc. 5, 415–420 (1973).
21. Wagner, H. & Nossal, G. J. V. Transpl. Rev. 17, 3–36 (1974).
22. Hammerling, G. J. Transpl. Rev. 30, 64–82 (1976).
23. Welsh, K. I., Burgos, H. & Batchelor, J. R. Eur. J. Immun. 7, 267–272 (1977).
24. Batchelor, J. R., Welsh, K. I. & Burgos, H. Transpl. Proc. 9, 931–936 (1977).
25. Hutchinson, I. V. & Zola, H. Transpl. Proc. 9, 961–963 (1977).



© 1977 Nature Publishing Group
Privacy Policy